Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

The Saudi Thoracic Society guidelines for influenza vaccinations.

Zeitouni MO, Al Barrak AM, Al-Moamary MS, Alharbi NS, Idrees MM, Al Shimemeri AA, Al-Hajjaj MS.

Ann Thorac Med. 2015 Oct-Dec;10(4):223-30. doi: 10.4103/1817-1737.167065.

2.

Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

Halasa NB, Gerber MA, Berry AA, Anderson EL, Winokur P, Keyserling H, Eckard AR, Hill H, Wolff MC, McNeal MM, Edwards KM, Bernstein DI.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):214-24. doi: 10.1093/jpids/piu061. Epub 2014 Jun 27.

PMID:
26334249
3.

Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.

Shinjoh M, Sugaya N, Yamaguchi Y, Tomidokoro Y, Sekiguchi S, Mitamura K, Fujino M, Shiro H, Komiyama O, Taguchi N, Nakata Y, Yoshida N, Narabayashi A, Myokai M, Sato M, Furuichi M, Baba H, Fujita H, Sato A, Ookawara I, Tsunematsu K, Yoshida M, Kono M, Tanaka F, Kawakami C, Kimiya T, Takahashi T, Iwata S; Keio Pediatric Influenza Research Group.

PLoS One. 2015 Aug 28;10(8):e0136539. doi: 10.1371/journal.pone.0136539. eCollection 2015.

4.

Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Feng L, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, Zhao G, Yu H.

Hum Vaccin Immunother. 2015;11(8):2077-101. doi: 10.1080/21645515.2015.1027470.

5.

Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.

Kim JR, Holbrook BC, Hayward SL, Blevins LK, Jorgensen MJ, Kock ND, De Paris K, D'Agostino RB Jr, Aycock ST, Mizel SB, Parks GD, Alexander-Miller MA.

J Virol. 2015 Jul;89(14):7291-303. doi: 10.1128/JVI.00549-15. Epub 2015 May 6.

6.

Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.

Alexander-Miller MA.

J Immunol. 2014 Dec 1;193(11):5363-9. doi: 10.4049/jimmunol.1401410. Review.

7.

Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study.

Waki N, Matsumoto M, Fukui Y, Suganuma H.

Lett Appl Microbiol. 2014 Dec;59(6):565-71. doi: 10.1111/lam.12340. Epub 2014 Oct 30.

8.

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants: randomized, observer-masked, single-center clinical study.

Wang S, Dong J, Chai W, Li F, Wang S, Sun B, Chen Z.

Springerplus. 2014 Jul 31;3:397. doi: 10.1186/2193-1801-3-397. eCollection 2014.

9.

Immunogenicity of the trivalent inactivated influenza vaccine in young children less than 4 years of age, with a focus on age and baseline antibodies.

Mugitani A, Ito K, Irie S, Eto T, Ishibashi M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Fukuoka Pediatricians Group for Vaccine Efficacy.

Clin Vaccine Immunol. 2014 Sep;21(9):1253-60. doi: 10.1128/CVI.00200-14. Epub 2014 Jul 2.

10.

Automated Screening of Hospitalized Children for Influenza Vaccination.

Pollack AH, Kronman MP, Zhou C, Zerr DM.

J Pediatric Infect Dis Soc. 2014 Mar;3(1):7-14. doi: 10.1093/jpids/pit044. Epub 2013 Aug 6.

11.

Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine.

Armstrong PK, Dowse GK, Effler PV, Carcione D, Blyth CC, Richmond PC, Geelhoed GC, Mascaro F, Scully M, Weeramanthri TS.

BMJ Open. 2011 May 30;1(1):e000016. doi: 10.1136/bmjopen-2010-000016.

12.

Influenza vaccination in young children reduces influenza-associated hospitalizations in older adults, 2002-2006.

Cohen SA, Chui KK, Naumova EN.

J Am Geriatr Soc. 2011 Feb;59(2):327-32. doi: 10.1111/j.1532-5415.2010.03271.x. Epub 2011 Jan 28.

13.

Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants.

D'Angio CT, Heyne RJ, Duara S, Holmes LC, O'Shea TM, Wang H, Wang D, Sánchez PJ, Welliver RC, Ryan RM, Schnabel KC, Hall CB; Premature Infant Vaccine Collaborative.

Pediatr Infect Dis J. 2011 Jul;30(7):570-4. doi: 10.1097/INF.0b013e31820c1fdf.

14.

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.

Usonis V, Anca I, André F, Chlibek R, Ivaskeviciene I, Mangarov A, Mészner Z, Prymula R, Simurka P, Tamm E, Tesović G, Central European Vaccination Advisory Group.

BMC Infect Dis. 2010 Jun 14;10:168. doi: 10.1186/1471-2334-10-168. Review.

15.

Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.

Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, Krahn M.

PLoS Med. 2010 Apr 6;7(4):e1000256. doi: 10.1371/journal.pmed.1000256.

16.

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children.

Nolan T, Richmond PC, McVernon J, Skeljo MV, Hartel GF, Bennet J, Basser RL.

Influenza Other Respir Viruses. 2009 Nov;3(6):315-25. doi: 10.1111/j.1750-2659.2009.00108.x.

17.

Recommendations for the use of influenza vaccine for children.

[No authors listed]

Paediatr Child Health. 2004 Sep;9(7):483-6. English, French. No abstract available.

18.

Immune response to influenza vaccine in children with inflammatory bowel disease.

Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A.

Am J Gastroenterol. 2009 Feb;104(2):444-53. doi: 10.1038/ajg.2008.120. Epub 2009 Jan 27.

19.

Antibody responses after inactivated influenza vaccine in young children.

Wright PF, Sannella E, Shi JR, Zhu Y, Ikizler MR, Edwards KM.

Pediatr Infect Dis J. 2008 Nov;27(11):1004-8. doi: 10.1097/INF.0b013e31817d53c5.

20.
Items per page

Supplemental Content

Write to the Help Desk